Economic diplomacy: Patent politics and trade deal twists
Biden’s jab
First it was new carbon emission cuts, and then a global minimum corporate tax. But it is hard to beat the Biden administration’s move to shaft the pharmaceutical industry lobby over vaccine patents for putting the US back at the heart of global public policy.
The devil will be in
By Greg Earl